Established in 2016, Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects. Our strategic goal is to support and enable companies we invest in to grow, create value and be successful by providing not only financial support, but also developmental, infrastructure and expertise support, as needed, through our global network. Our approach is to establish long-term relationships with target companies, with a view to enable and strengthen management to realize the full potential and value of the technology. This approach has previously been successfully demonstrated in the energy and high-tech sectors where Quark Venture partners have invested.
22
Total Investments
18
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About GHS Fund
Recent Investments (22)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Dec 2022 | |
| Series C - V | •••••• | Dec 2021 | |
| Series C | •••••• | Jun 2021 | |
| Series D | •••••• | Mar 2021 | |
| Series A | •••••• | Feb 2020 | |
|
|
Series B | •••••• | Jan 2020 |
|
|
Series C | •••••• | Dec 2019 |
|
|
Series C | •••••• | Dec 2019 |
|
|
Series B | •••••• | May 2019 |
|
|
Series B | •••••• | Feb 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.